Swiss National Bank’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-50,100
| Closed | -$5.38M | – | 2687 |
|
|
2023
Q1 | $5.38M | Sell |
50,100
-6,000
| -11% | -$644K | ﹤0.01% | 1223 |
|
|
2022
Q4 | $6.17M | Buy |
56,100
+33,100
| +144% | +$3.64M | ﹤0.01% | 1188 |
|
|
2022
Q3 | $1.36M | Hold |
23,000
| – | – | ﹤0.01% | 2144 |
|
|
2022
Q2 | $649K | Sell |
23,000
-4,600
| -17% | -$130K | ﹤0.01% | 2544 |
|
|
2022
Q1 | $1.04M | Buy |
27,600
+1,900
| +7% | +$71.7K | ﹤0.01% | 2387 |
|
|
2021
Q4 | $1.02M | Buy |
+25,700
| New | +$1.02M | ﹤0.01% | 2473 |
|